Navigation Links
Immureboost Inc Announces a Change of Name to Fountain Healthy Aging Inc
Date:9/5/2008

LOS ANGELES, California, September 5 /PRNewswire/ --

- Exchange: OTCBB

Immureboost Inc. announced on September 5th 2008 a name change to Fountain Healthy Aging Inc.

Fountain Healthy Aging Inc. said this approval follows the earlier approval of the name change by the Board of Directors and the Shareholders of the Company.

CEO, Dr Tony Jimenez said a name change "was appropriate as we have a new direction and a completely new business plan "

Dr Jimenez went on to say that; "Fountain Healthy Aging Inc. will be a pioneer in the anti- aging industry with our new flagship product Vitalife. Vitalife is the world's first and only transdermal growth hormone releasing hormone (GHRH) analog. Studies show statistically significant increases in hGH levels from baseline, after treatment with Vitalife."

Currently the Anti-aging industry is a US$30 Billion market. We estimate that this industry will grow by US$12 Billion in the next year and a half alone, and to US$70 Billion in the next 3 years. The worldwide global anti aging market is expected to reach US$115.5 Billion by 2010, and is now one of the fastest growing business segments in the world.

In the next few months, Fountain Healthy Aging, will focus on transitioning Vitalife into the mass market. Our existing clinical data will be bolstered by 5 additional clinical trials conducted in countries around the world that will provide further evidence of the product's safety and efficacy.

About Fountain Healthy Aging

Fountain Healthy Aging is a company specifically focussed in the anti aging industry, which is one of the quickest growing industry sectors worldwide. We have a range of products targeted at the anti aging market, including our revolutionary flagship product Vitalife, which we believe is ready to make a massive impact in the anti-aging industry. We recognize the importance of the anti-aging sector, an emerging dynamic within the overall health and
'/>"/>

SOURCE Fountain Healthy Aging Inc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
3. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
4. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
5. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
11. CNS Response Announces Fiscal Third Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/30/2015)... 30, 2015 Cytokinetics, Incorporated (Nasdaq: CYTK) reported ... 2015 were $4.4 million, compared to $8.0 million during the ... first quarter was $8.9 million, or $0.23 per basic and ... the same period in 2014, of $8.7 million, or $0.27 ... 2015, cash, cash equivalents and investments totaled $117.5 million. ...
(Date:4/30/2015)... 2015 The following is an open letter sent ... Cord Blood Corp (NYSE: CO ) from Jayhawk Capital. ... independent directors of China Cord Blood Corp (" China Cord ... per share from Golden Meditech Holdings Co Ltd ("Golden Med"). ... greatly benefit Golden Med and Mr. Kam, the Chairman of ...
(Date:4/30/2015)... Calif. , April 30, 2015  Asterias Biotherapeutics, ... the emerging field of regenerative medicine, today announced that ... on Thursday, May 7, 2015 after the close of ... conference call and webcast on Thursday, May 7, 2015 ... discuss the results and recent corporate developments. ...
(Date:4/30/2015)... Available in select spas in the ... Phytomer’s DOUCEUR INTEMPORELLE Restorative Shield Cream provides immediate ... the weakening threat of inflammaging, aging directly caused ... star ingredient GLYCOSEA, a complex of restructuring plankton ... soothing minerals and trace elements. GLYCOSEA works to ...
Breaking Biology Technology:Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 2Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 3Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 4Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 5Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 6Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 7Cytokinetics, Incorporated Reports First Quarter 2015 Financial Results 8April 30, 2015 Open Letter to the Board of China Cord Blood Corp from Jayhawk Capital 2April 30, 2015 Open Letter to the Board of China Cord Blood Corp from Jayhawk Capital 3April 30, 2015 Open Letter to the Board of China Cord Blood Corp from Jayhawk Capital 4April 30, 2015 Open Letter to the Board of China Cord Blood Corp from Jayhawk Capital 5Asterias Biotherapeutics to Report First Quarter Results on May 7, 2015 2Asterias Biotherapeutics to Report First Quarter Results on May 7, 2015 3Phytomer introduces DOUCEUR INTEMPORELLE Restorative Shield Cream 2Phytomer introduces DOUCEUR INTEMPORELLE Restorative Shield Cream 3
... ANNAPOLIS, Md., March 20 PharmAthene, Inc.,(Amex: ... against,biological and chemical threats, today reported the company ... ended December 31, 2007. The earnings,release was previously ... the new date and time of its earnings ...
... Hutchinson Cancer Research,Center (FHCRC) and NSB POSTECH, Inc. ... efforts and to determine the efficacy of the,NSB,s ... to be used in the study of human ... company which possesses a proprietary,microarray technology and a ...
... non-healing leg ulcers each year in the US, ... (OTC Bulletin Board: DSCI), provider of advanced wound ... abstracts detailing the clinical usage,of its newly released ... presented at the annual American Professional Wound Care,Association ...
Cached Biology Technology:Fred Hutchinson Cancer Research Center and NSB POSTECH, Inc. to Collaborate on Development of New Class of Proteomic Microarrays 2Derma Sciences Announces Clinical Poster on Use of MEDIHONEY(TM) Wound & Burn Dressings Wins First Place Award at APWCA 2Derma Sciences Announces Clinical Poster on Use of MEDIHONEY(TM) Wound & Burn Dressings Wins First Place Award at APWCA 3Derma Sciences Announces Clinical Poster on Use of MEDIHONEY(TM) Wound & Burn Dressings Wins First Place Award at APWCA 4
(Date:4/2/2015)... -- According to preliminary estimates Fingerprint Cards, ... than 125 MSEK. This exceeds the guidance provided by ... for Q1 2015 would be in line with the ... The operating result for the first quarter is estimated ... will as previously communicated be published on May 21. ...
(Date:4/1/2015)...   Medisafe ™, the leading global medication management ... and Android smartphones and tablets, announces ... platform to allow patients to track and correlate their ... patients will be able to visualize in real-time how ... such as glucose levels and blood pressure. ...
(Date:3/30/2015)... Research and Markets ( http://www.researchandmarkets.com/research/lc9bnl/global_gesture ) ... Recognition Market in Automotive Sector 2014-2018" report to ... Gesture Recognition market in Automotive Sector to grow at ... Gesture recognition is the ability of a device ... individual. Gesture recognition technology can be 2D-based or 3D-based. ...
Breaking Biology News(10 mins):Fingerprint Cards Revises Revenues for Q1 2015 2Medisafe Announces Launch of Biometric Integration, Enabling Patients to Stay Adherent to Their Meds and See Tangible Health Results 2Global Gesture Recognition Market in Automotive Sector Report 2015 - Growing Number of Partnerships 2
... London) finds that a high-prevalence of male-killing bacteria active in ... promiscuity and male fatigue. , The team found that when ... bacteria -- the female butterfly becomes more sexually rampant. Males ... less effort into mating. , In some populations ...
... flu virus's hemagglutinin receptor binding site—a molecular structure critical ... according to a new study conducted by researchers at ... for Disease Control and Prevention. The finding, published in ... clinical implications in helping scientists develop ways to break ...
... a team of University of Georgia scientists suggests that ... do little ?if anything ?to reduce rates of antibiotic ... health. , Dr. Margie Lee, professor in the ... found that chickens raised on antibiotic-free farms and even ...
Cached Biology News:Male-killing bacteria makes female butterflies more promiscuous 2Changes in amino acids in the 1918 influenza virus cut transmission 2Changes in amino acids in the 1918 influenza virus cut transmission 3Study finds antibiotic resistance in poultry even when antibiotics were not used 2Study finds antibiotic resistance in poultry even when antibiotics were not used 3
Human DC-SIGNR/CD209L MAb (Clone 120604)...
Human DPPII/QPP/DPP7 Biotinylated Affinity Purified PAb ENTREZ GeneID: 29952...
Human SorCS1 Affinity Purified Polyclonal Ab Protein Family: Neurotrophins...
Human Apolipoprotein B100 Affinity Purified Polyclonal Ab ENTREZ GeneID: 338...
Biology Products: